June 23, 2026 Phillips Edison & Company Inc. Invites You to Join Its Second Quarter 2026 Earnings Conference Call
June 23, 2026 Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease
June 23, 2026 3 E Network Technology Group Limited Announces Initial Closing of US$2 Million Convertible Promissory Note Offering
